Virpax Pharmaceuticals Receives Nasdaq Panel Decision, Granted Listing Continuation with Conditions
On January 6, 2025, Virpax Pharmaceuticals, Inc. announced in a Form 8-K filing that it had received a decision from the Nasdaq Hearings Panel regarding its listing on The Nasdaq Stock Market. The Panel granted the Company’s request to continue its listing, subject to specific conditions outlined in the decision. The Nasdaq Hearings Panel’s decision […]
More Stories
ST Germain D J Co. Inc. Has $12.10 Million Position in AbbVie Inc. (NYSE:ABBV)
ST Germain D J Co. Inc. raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.8% during the...
Seagate Technology Holdings plc (NASDAQ:STX) Shares Bought by CCM Investment Advisers LLC
CCM Investment Advisers LLC boosted its stake in shares of Seagate Technology Holdings plc (NASDAQ:STX – Free Report) by 2.8%...
IRADIMED Reports Record Revenues for Q4 2024 and Full-Year 2024
Iradimed Corporation (NASDAQ: IRMD), a company specializing in innovative Magnetic Resonance Imaging (MRI) compatible medical devices, has released its preliminary...
ST Germain D J Co. Inc. Purchases 306 Shares of McDonald’s Co. (NYSE:MCD)
ST Germain D J Co. Inc. raised its position in McDonald’s Co. (NYSE:MCD – Free Report) by 2.0% in the...
Wealth Enhancement Advisory Services LLC Increases Stake in Costco Wholesale Co. (NASDAQ:COST)
Wealth Enhancement Advisory Services LLC lifted its position in shares of Costco Wholesale Co. (NASDAQ:COST – Free Report) by 0.8%...
Challenger Energy Group (LON:CEG) Trading Up 12.4% – What’s Next?
Challenger Energy Group PLC (LON:CEG – Get Free Report) was up 12.4% on Friday . The stock traded as high...